Wednesday, July 8, 2026

biotech · Head and Neck Cancer · Solid Tumor · PPBT

PURPLE BIOTECH

Purple Biotech is a biotech organization headquartered in REHOVOT, L3, USA. It trades on NYSE under ticker PPBT. Primary therapeutic focus areas include Head and Neck Cancer, Solid Tumor, Solid Tumor, Adult. NovaPharmaNe

REHOVOT, L3, USA HQ
2010 Founded
12 Employees
Public company Type
PPBT · NYSE Ticker
Company details
Status
Public
HQ
REHOVOT, L3, USA
Founded
2010
Employees
12
Programs
3
Drugs
4
Patents
3
Clinical program

NT219

Phase 2 · small molecule · Solid Tumor, Adult

NT219 for Solid Tumor, Adult is a Phase 2 program (small_molecule) at PURPLE BIOTECH LTD. with 1 ClinicalTrials.gov record(s).

← All PURPLE BIOTECH LTD. projects Phase 2 small molecule completed

Internal code TYR-219-01

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
PURPLE BIOTECH LTD.
Phase
Phase 2
Modality
small_molecule
Indication
Solid Tumor, Adult
Status
completed
Trials
1

Clinical trials